Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Post by everswannon Feb 05, 2008 8:40pm

96 Views

Post# 14323048

TH hasn''t presented yet

From what I gather TH hasn't presented yet. I know Saurus said yesterday but - external evidences point to the contrary. Will Thursday Feb 7th. Check out: https://www.bloomberg.com/apps/news?pid=20601109&sid=a7V1aRkyWFWw&refer=home Check out; https://www.retroconference.org/2008/display.asp?page=394 TH data should be the only "positive thing" this year!

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”